Lavinia Biamonte

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

N. Munshi, C. Mignogna, P. Tassone, 2017, Leukemia.

Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan

V. Mazzaferro, L. Biamonte, M. Platania, 2020, Clinical Colorectal Cancer.

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo

K. Anderson, N. Munshi, P. Tassone, 2015, Leukemia.

A p53‐Dependent Tumor Suppressor Network Is Induced by Selective miR‐125a‐5p Inhibition in Multiple Myeloma Cells

P. Tassone, P. Tagliaferri, A. Giordano, 2014, Journal of cellular physiology.

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells

P. Tassone, T. Calimeri, P. Tagliaferri, 2013, Cell cycle.

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92.

N. Munshi, P. Tassone, P. Tagliaferri, 2018, Blood.

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a 1 first-in-class inhibitor of pri-mir-17-92 2

P. Tagliaferri, A. Neri, M. Fulciniti, 2018 .